相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD314 (NKG2D)
- 级别:
CD314 (NKG2D) Antibody
- 目录编号:
CD314 (NKG2D) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
CD314 (NKG2D) Antibody
- 抗体英文名:
anti-human CD314 (NKG2D) Antibody-APC
- 抗体名:
CD314 (NKG2D) Antibody
- 标记物:
APC
- 宿主:
小鼠
- 适应物种:
人
- 免疫原:
CD314 (NKG2D) Antibody
- 亚型:
CD314 (NKG2D) Antibody
- 形态:
CD314 (NKG2D) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
CD314 (NKG2D) Antibody
- 规格:
25 tests/100 tests
| 规格: | 25 tests | 产品价格: | ¥2500.0 |
|---|---|---|---|
| 规格: | 100 tests | 产品价格: | ¥5100.0 |
anti-human CD314 (NKG2D) Antibody-APC详细如下:
Description :CD314 is a homodimeric C-type lectin-like protein also known as NKG2D. It is expressed on NKcells, CD8 T cells, γ/δ T cells, and in vitro induced LAK cells. Several molecules have beenidentified as the ligands for NKG2D, including MHC class-I chain-related protein A (MICA),MICB, and UL16-binding proteins (ULBPs). NKG2D has no intrinsic signaling capacity, butattains this by non-covalent association with DAP10 or DAP12 adaptors. In addition to being aprimary activation receptor on NK cells, NKG2D is also a costimulatory receptor for TCRmediated T cell proliferation and cytokine production. The interaction of NKG2D with its ligandsplays a role in the immune surveillance against pathogen and tumor cells, and in thepathogenesis of autoimmune diseases.
Verified Reactivity :Human
Reported Reactivity :African Green, Baboon, Cynomolgus, Rhesus
Antibody Type :Monoclonal
Host Species :Mouse
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography, and conjugated with APC under optimalconditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser :Red Laser (633 nm)
Description :CD314 is a homodimeric C-type lectin-like protein also known as NKG2D. It is expressed on NKcells, CD8 T cells, γ/δ T cells, and in vitro induced LAK cells. Several molecules have beenidentified as the ligands for NKG2D, including MHC class-I chain-related protein A (MICA),MICB, and UL16-binding proteins (ULBPs). NKG2D has no intrinsic signaling capacity, butattains this by non-covalent association with DAP10 or DAP12 adaptors. In addition to being aprimary activation receptor on NK cells, NKG2D is also a costimulatory receptor for TCRmediated T cell proliferation and cytokine production. The interaction of NKG2D with its ligandsplays a role in the immune surveillance against pathogen and tumor cells, and in thepathogenesis of autoimmune diseases.
Verified Reactivity :Human
Reported Reactivity :African Green, Baboon, Cynomolgus, Rhesus
Antibody Type :Monoclonal
Host Species :Mouse
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography, and conjugated with APC under optimalconditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser :Red Laser (633 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Wu J, et al. 1999. Science 285:730.
2. Wu J, et al. 2000. J. Exp. Med. 192:1059.
3. Groh V, et al. 2001. Nature Immunol. 2:255.
4. Wu J, et al. 2002. J. Immunol. 169:1236.
5. Roberts A, et al. 2001. J. Immunol. 167:5527.
6. Groh V, et al. 2003. Proc. Natl. Acad. Sci. USA 100:9452.
7. Kraetzel K et al. 2008. Eur. Respir. J. 32:563. PubMed
8. Correia DV, et al. 2011. Blood 118:992. (FC) PubMed
9. Watanbe M, et al. 2014. Int Immunol. PubMed
Product Citations:
1. Wang H, et al. 2022. Front Immunol. 13:852436. PubMed
2. Jeon SB, et al. 2022. Int J Stem Cells. Online ahead of print. PubMed
3. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
4. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
5. Gao Y, et al. 2021. Oncogenesis. 10:62. PubMed
6. Watanabe M, et al. 2014. Int Immunol. 26:597. PubMed
7. de Jonge K et al. 2019. Scientific reports. 9(1):4487 . PubMed
8. Welsh JA, et al. 2022. Cell Rep Methods. 2:100136. PubMed
9. Wu X, et al. 2020. Cancers (Basel). 12:. PubMed
10. Sun B, et al. 2019. Cancer Immunol Res. 1.550694444. PubMed
11. Paidipally P, et al. 2009. J Immunol. 183:1940. PubMed
12. Bigler M, et al. 2015. PLoS One. 10: 0145635. PubMed
1. Wu J, et al. 1999. Science 285:730.
2. Wu J, et al. 2000. J. Exp. Med. 192:1059.
3. Groh V, et al. 2001. Nature Immunol. 2:255.
4. Wu J, et al. 2002. J. Immunol. 169:1236.
5. Roberts A, et al. 2001. J. Immunol. 167:5527.
6. Groh V, et al. 2003. Proc. Natl. Acad. Sci. USA 100:9452.
7. Kraetzel K et al. 2008. Eur. Respir. J. 32:563. PubMed
8. Correia DV, et al. 2011. Blood 118:992. (FC) PubMed
9. Watanbe M, et al. 2014. Int Immunol. PubMed
Product Citations:
1. Wang H, et al. 2022. Front Immunol. 13:852436. PubMed
2. Jeon SB, et al. 2022. Int J Stem Cells. Online ahead of print. PubMed
3. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
4. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
5. Gao Y, et al. 2021. Oncogenesis. 10:62. PubMed
6. Watanabe M, et al. 2014. Int Immunol. 26:597. PubMed
7. de Jonge K et al. 2019. Scientific reports. 9(1):4487 . PubMed
8. Welsh JA, et al. 2022. Cell Rep Methods. 2:100136. PubMed
9. Wu X, et al. 2020. Cancers (Basel). 12:. PubMed
10. Sun B, et al. 2019. Cancer Immunol Res. 1.550694444. PubMed
11. Paidipally P, et al. 2009. J Immunol. 183:1940. PubMed
12. Bigler M, et al. 2015. PLoS One. 10: 0145635. PubMed
文献支持
抗人 CD314 (NKG2D) 荧光标记APC 抗体
¥2500 - 5100










